NCT03337386

Subclavian Versus Inferior Vena Cava Collapsibility Indices.

Completed NA Last updated 18 September 2020

What this trial tests

NA trial testing inferior vena cava collapsibility in Hemodynamic Instability in 64 participants. Completed in 20 May 2018.

Timeline

12 November 2017

Primary endpoint
10 April 2018

20 May 2018

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	64
Start date	12 November 2017
Primary completion	10 April 2018
Estimated completion	20 May 2018
Sites	1 location across Egypt

Drugs / interventions tested

• inferior vena cava collapsibility
• subclavian vein collapsibility
• central venous pressure

Conditions studied

• Hemodynamic Instability — all drugs for Hemodynamic Instability →

Sponsor

Mansoura University

Who can join

Adults 20 to 60, any sex, with Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Traditional methods for intravascular volume status assessment include physical examination, raised leg test, central venous pressure (CVP) and pulmonary artery catheters occlusion pressure (PAWP). Central venous pressure and pulmonary artery occlusion pressure are invasive and associated with significant complications. More recently, a number of less invasive techniques have been introduced, but they lack standardization and reliability. Ultrasonically, inferior vena cava collapsibility can detect hypovolemia non-invasively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.